Imagion Biosystems announced on ASX that it has received a total of $81,256.85 for the exercise of options.
Please click to review the full announcement at ASX.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the